Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab (IRIS/Bev) in patients with metastatic colorectal cancer: Update analysis—Hokkaido Gastrointestinal Cancer Study Group (HGCSG) trial.
Satoshi Yuki
No relevant relationships to disclose
Yoshito Komatsu
No relevant relationships to disclose
Takuto Miyagishima
No relevant relationships to disclose
Takashi Kato
No relevant relationships to disclose
Kazuteru Hatanaka
No relevant relationships to disclose
Michio Nakamura
No relevant relationships to disclose
Mineo Kudo
No relevant relationships to disclose
Nobuaki Akakura
No relevant relationships to disclose
Miki Tateyama
No relevant relationships to disclose
Yuh Sakata
No relevant relationships to disclose